Examination Report |
1 | Additional Representation Sheet | 09 Nov 2010 |
10 | Hearing Notice | 10 Oct 2017 |
11 | Hearing Notice | 03 Jan 2018 |
12 | Journal Copy | 23 Mar 2018 |
13 | Certificate | 13 Jun 2018 |
14 | TM-R(RENEWAL OF TRADE MARK) | 17 Dec 2019 |
2 | TM-1 | 09 Nov 2010 |
3 | Correspondence | 03 Sep 2012 |
3 | TM-16 | 03 Sep 2012 |
4 | Authorization Document (POA) | 03 Sep 2012 |
4 | TM-16 | 03 Sep 2012 |
5 | Authorization Document (POA) | 03 Sep 2012 |
5 | Correspondence | 03 Sep 2012 |
6 | Correspondence | 14 Nov 2013 |
7 | TM-16 | 21 May 2015 |
8 | Reply to Exam Report (MIS-R) | 04 Sep 2017 |
9 | Hearing Notice | 05 Oct 2017 |
1 | Hearing Notice (Show Cause) | 5162336 | 28 Sep 2017 | |
2 | Hearing Notice (Adjourned) | 5470807 | 27 Nov 2017 | |
3 | Tribunal ABA Notice for : 2051005 | 5701713 | 12 Jan 2018 | |
4 | RENEWAL INTIMATION LETTER | 9625021 | 22 Jan 2020 |
The application for Ra-quin was made on 09 November 2010.
The trademark applicant for Ra-quin is SUN PHARMACEUTICAL INDUSTRIES.
Ra-quin is applied in class(es) 5.
Application for Ra-quin is on Registered stage.
Application Id allotted to Ra-quin is 2051005.
Ra-quin filed with the Intellectual property office as a WORD.